Implantable cardioverter-defibrillators do not appear to be associated with a reduced risk of death in women with advanced heart failure, according to a meta-analysis of previously published research ...

The global implantable defibrillator market is projected to grow at a steady CAGR of ~7% during the forecast period, driven by rising cardiovascular disease prevalence, rapid technological innovation, ...

The indications for ICD implantation continue to expand; however, these devices are associated with complications related to the implantation procedure itself and morbidity caused by the normal and ...

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Prophylactic implantation of an implantable cardioverter defibrillator within 90 days of ...

Medtronic has put forward a clinical study showing the success of a new type of minimally invasive defibrillator implant designed to interrupt a sudden cardiac arrest. Compared to traditional ...

There are unique technical issues that must be considered with the implantation of devices in small patients and those with CHD. Although most centers report low complication rates of complications in ...

Almost exactly a year after beginning a recall of some of its implantable defibrillator devices that were found to potentially emit electrical pulses below their programmed strength, Medtronic has ...

Presenter: Stuart J. Connolly, MD, McMaster University (Hamilton, Ontario, CANADA) and Stefan H. Hohnloser, MD, J.W. Goethe University (Frankfurt, Germany) Large randomized clinical trials have ...

Is the routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial infarction survivors with heart failure still an adequate therapy for prevention of sudden cardiac death?

BALTIMORE – Dr. Morton Mower, a former Maryland-based cardiologist who helped invent an automatic implantable defibrillator that has helped countless heart patients live longer and healthier, has died ...